Roflumilast 68382-0969
Product NDC
68382-0969- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 3, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208303
Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Roflumilast | 500 ug/1 |
Drug Class
Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]
Packaging Options(2)
30 TABLET in 1 BOTTLE (68382-969-06)
90 TABLET in 1 BOTTLE (68382-969-16)